November 4, 2015
Recent Developments in the Treatment of Non-small Cell Lung Cancer
Dinner at 5:45 p.m. Program to follow at 6:15 p.m.
Medical and Radiation Oncologists, Cardiovascular Thoracic Surgeons, all other interested physicians who care for cancer patients, mid-level providers and all other interested health care professionals.
Martin J. Edelman, M.D.
Dr. Edelman completed his medical education at The Albany Medical College in Albany, New York. He completed his internship in Internal Medicine at the Naval Hospital in San Diego, California, and his residency in Internal Medicine at the Naval Hospital in San Diego, California. Dr. Edelman also completed a Hematology/Oncology fellowship at the Naval Hospital in San Diego, California. He is professionally associated with the University of Maryland.
At the completion of this activity, the participant should be able to:
- Examine current indications and recent clinical trial results and ongoing studies regarding the adjuvant therapy of resected lung cancer.
- Inspect current approaches and recent clinical trial results regarding the treatment of locally advanced (stage III) NSCLC.
- Discuss the results and ongoing studies with immunotherapy for NSCLC.
Professional Practice Gap to be filled: Knowledge of best practices and evidence-based medicine for the treatment of lung cancer.
FirstHealth of the Carolinas is accredited by the North Carolina Medical Society (NCMS) to provide continuing medical education for physicians.
FirstHealth of the Carolinas designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is being offered by FirstHealth’s Office of Continuing Medical Education.
Please contact us if ADA accommodations are needed.
Please call Corporate Education at (910) 715-1582 or 715-1583, or register online, to reserve your space and dinner.